Related Experiment Videos
Unified Huntington's disease rating scale: a follow up
S Siesling1, J P van Vugt, K A Zwinderman
1Department of Neurology, Leiden University Medical Centre, The Netherlands.
Insights
The Unified Huntington's Disease Rating Scale (UHDRS) effectively tracks Huntington's disease progression, showing declines in motor function and independence over one year. Annual motor assessments are recommended for monitoring disease advancement.
Area of Science:
- Neurology
- Clinical Neuroscience
- Neurodegenerative Diseases
Background:
- Objective assessment of Huntington's disease (HD) clinical features is crucial for understanding disease progression.
- The Unified Huntington's Disease Rating Scale (UHDRS) is a standardized tool for evaluating clinical performance and functional capacity in HD patients.
Purpose of the Study:
- To assess the 1-year change in UHDRS scores in patients with Huntington's disease.
- To evaluate the utility of the UHDRS for longitudinal monitoring and therapeutic intervention assessment.
Main Methods:
- Longitudinal study involving 78 Huntington's disease patients across two international sites.
- Annual assessment using the Unified Huntington's Disease Rating Scale (UHDRS), including motor, functional, and behavioral measures.
Main Results:
- Significant decline observed in motor function (total motor scale) and functional capacity (independence scale, total functional capacity, symbol digit).
- Significant increase in total dystonia score; chorea score remained unchanged.
- Behavioral disorder frequency showed a tendency to increase.
- No correlation found between UHDRS scores and age at onset or disease duration.
Conclusions:
- The UHDRS is a valuable tool for monitoring Huntington's disease progression, particularly motor decline.
- Annual evaluation of the total motor scale is suggested for tracking motor progression.
- A comprehensive UHDRS evaluation every two years is recommended for routine longitudinal assessment.
Abstract:
An objective assessment of the clinical findings in patients with Huntington's disease (HD) is necessary for an evaluation of the longitudinal progression of the disease features. The Unified Huntington's Disease Rating Scale (UHDRS) is a scale to assess clinical performance and functional capacity. The authors examined the 1-year change in UHDRS scores in 78 patients with HD examined either in Leiden, the Netherlands (24 men, 25 women), or in Rochester, New York, United States (12 men, 17 women). A significant decline was seen in motor function, measured with the total motor scale. The total dystonia score increased significantly; the total chorea score did not. The frequency of behavioral disorders tended to increase. The scores on independence scale, functional assessment, total functional capacity, and symbol digit decreased significantly. No relation was observed between the UHDRS items and the age at onset or duration of illness. Thirteen patients with 2-year follow up showed a clear increase in score on the total motor scale and a decline on the independence scale and in total functional capacity. The UHDRS may also be used as a tool for determining therapeutic intervention. Annual evaluation of the total motor scale in every patient gives a clear description of the motor progression of the disease. The authors suggest performing a total UHDRS evaluation every second year for every HD patient as part of the routine longitudinal evaluation.